Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis

J Diabetes Complications. 2017 Mar;31(3):605-610. doi: 10.1016/j.jdiacomp.2016.11.005. Epub 2016 Nov 12.

Abstract

Background: Retinopathy is increasingly recognized in prediabetic populations, and may herald increased risk of metabolic worsening. The Early Diabetes Intervention Program (EDIP) evaluated worsening of glycemia in screen-detected Type 2 diabetes, following participants for up to 5years. Here we have evaluated whether the presence of retinopathy at the time of detection of diabetes was associated with accelerated progression of glycemia.

Methods: We prospectively studied 194 participants from EDIP with available baseline retinal photographs. Retinopathy was determined at baseline using 7-field fundus photography and defined as an Early Treatment of Diabetic Retinopathy Study Scale grading score of ≥20.

Results: At baseline, 12% of participants had classical retinal lesions indicating retinopathy. In univariate Cox proportional hazard analysis, the presence of retinopathy at baseline was associated with a doubled risk of progression of fasting plasma glucose (HR 2.02; 95% CI 1.05-3.89). The retinopathy effect was robust to individual adjustment for age and glucose, the most potent determinants of progression in EDIP.

Conclusion: Retinopathy was associated with increased risk of progression of fasting plasma glucose among adults with screen-detected, early diabetes. Early detection of retinopathy may help individualize more aggressive therapy to prevent progressive metabolic worsening in early diabetes.

Keywords: Diabetes; Early diabetes; Microvascular disease; Prediction; Retinopathy.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Blood Glucose / analysis
  • Cohort Studies
  • Combined Modality Therapy
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetes Mellitus, Type 2 / therapy
  • Diabetic Retinopathy / diagnostic imaging*
  • Diabetic Retinopathy / epidemiology
  • Diabetic Retinopathy / prevention & control
  • Disease Progression
  • Disease-Free Survival
  • Early Diagnosis
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperglycemia / prevention & control*
  • Male
  • Mass Screening
  • Middle Aged
  • Midwestern United States / epidemiology
  • Prevalence
  • Proportional Hazards Models
  • Prospective Studies
  • Retina / diagnostic imaging*
  • Risk Factors

Substances

  • Blood Glucose